Clinical Trial

High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 15, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.
Trial Details
NCT Number NCT07172542
Lead Sponsor Centre Hospitalier de Gonesse
Conditions Intracerebral Hemorrhage, Cerebral Hemorrhage, Stroke, Brain Injuries
Enrollment 50 participants
Start Date 2025-10-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-15